SENTI BIOSCIENCES, INC. — Form D
SENTI BIOSCIENCES, INC. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-26. The offering totals $53.4M, of which $39.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-02-26
- Form: D
- Accession: 0001732195-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $53.4M
- Amount sold: $39.4M
- Remaining: $14.0M
- Investors: 26
- Date of first sale: 2018-02-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-306382
Issuer
- Name: SENTI BIOSCIENCES, INC.
- CIK: 0001732195
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 329 OYSTER POINT BLVD 3RD FL, SAN FRANCISCO, CA, 94080
- Phone: 650-382-3281
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Alex Kolicich | Director | WALTHAM, MA |
| Timothy Lu | Director | South San Francisco, CA |
| Ed Mathers | Director | TIMONIUM, MD |
| Philip Lee | Executive Officer | New York, NY |
| Timothy Lu | Executive Officer | South San Francisco, CA |
More